Dr Ibou Thior

Dr Ibou Thior is a Senior Technical Adviser at PATH and the Principal investigator for the CDC Global TB Technical Assistance (2023 – 2028). He is a senior health professional with more than twenty years of experience in HIV/TB/viral hepatitis research, program implementation and evaluation in countries with generalized and localized epidemics. Before joining PATH, Dr Thior was the Project Director of the Botswana Harvard AIDS Institute Partnership in Gaborone where he led several PMTCT, ART and HIV vaccine trials and supported the Ministry of Health of Botswana in their efforts to eliminate PMTCT.

In Senegal, where he completed medical training and started his career as a researcher, he worked as a study physician in the national center for sexually transmitted diseases where he led a clinical cohort study of sex workers for almost a decade and collaborated with biologists working on HIV, STI and hepatitis B.

Dr Thior has a medical degree from Cheikh Anta Diop University (Senegal), a MS in epidemiology from Harvard School of Public Health, and an MBA from George Washington University. He is fluent in French and English, with a working knowledge of Spanish and has authored/co-authored several peer-reviewed publications with research teams in different countries.